BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Net income 2018–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$22.4MFY2025 · since FY2018: -$8.9M → $22.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.4M | +132.1% |
| FY2024 | -$69.7M | +15.5% |
| FY2023 | -$82.4M | +9.6% |
| FY2022 | -$91.2M | +27.4% |
| FY2021 | -$125.6M | -86.7% |
| FY2020 | -$67.3M | -90.7% |
| FY2019 | -$35.3M | -294.8% |
| FY2018 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BDTX financial trends
BDTX RevenueBDTX Net marginBDTX Gross profitBDTX Gross marginBDTX Operating incomeBDTX Operating marginBDTX Operating cash flowBDTX Free cash flowBDTX Capital expendituresBDTX Return on equityBDTX Stock buybacksBDTX Dividends paidBDTX Total assetsBDTX Total liabilitiesBDTX Shareholders’ equityBDTX overview →